# Cefar URO - Symptomatic Treatment of Overactive Bladder

> **NCT06659536** · NA · NOT_YET_RECRUITING · sponsor: **DJO UK Ltd** · enrollment: 53 (estimated)

## Conditions studied

- Overactive Bladder (OAB)
- Refractory Overactive Bladder
- Urinary Urgency and Frequency

## Interventions

- **DEVICE:** Transcutaneous Tibial Nerve Stimulation (TTNS) with the Cefar Uro Device

## Key facts

- **NCT ID:** NCT06659536
- **Lead sponsor:** DJO UK Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2026-03
- **Final completion:** 2026-03
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06659536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06659536, "Cefar URO - Symptomatic Treatment of Overactive Bladder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06659536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*